Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1
Authors:
- Madalena BarrosoMBMadalena Barroso
- Marcus GertzenMGMarcus Gertzen
- Alexandra F. Puchwein-SchwepckeAPAlexandra F. Puchwein-Schwepcke
- Heike PreislerHPHeike Preisler
- Andreas SturmASAndreas Sturm
- Dunja D. ReissDRDunja D. Reiss
- Marta K. DaneckaMDMarta K. Danecka
- Ania C. MuntauAMAnia C. Muntau
- Søren W. GerstingSGSøren W. Gersting
Open Access
- 24 August 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13158
Abstract
Glutaric acidemia type 1 (GA1) is a neurotoxic metabolic disorder due to glutaryl-CoA dehydrogenase (GCDH) deficiency. The high number of missense variants associated with the disease and their impact on GCDH activity suggest that disturbed protein conformation can affect the biochemical phenotype. We aimed to elucidate the molecular basis of protein loss of function in GA1 by performing a parallel analysis in a large panel of GCDH missense variants using different biochemical and biophysical methodologies. Thirteen GCDH variants were investigated in regard to protein stability, hydrophobicity, oligomerization, aggregation, and activity. An altered oligomerization, loss of protein stability and solubility, as well as an augmented susceptibility to aggregation were observed. GA1 variants led to a loss of enzymatic activity, particularly when present at the N-terminal domain. The reduced cellular activity was associated with loss of tetramerization. Our results also suggest a correlation between variant sequence location and cellular protein stability (p < 0.05), with a more pronounced loss of protein observed with variant proximity to the N-terminus. The broad panel of variant-mediated conformational changes of the GCDH protein supports the classification of GA1 as a protein-misfolding disorder. This work supports research toward new therapeutic strategies that target this molecular disease phenotype.Keywords
Funding Information
- Else Kröner-Fresenius-Stiftung—Rare immune system diseases
- medical school of Ludwig-Maximilians-University
- Open Access Publication Fund of UKE—Universitätsklinikum Hamburg-Eppendorf
- DFG-German Research Foundation
This publication has 59 references indexed in Scilit:
- Exome sequencing identifies GCDH (glutaryl-CoA dehydrogenase) mutations as a cause of a progressive form of early-onset generalized dystoniaHuman Genetics, 2011
- Biophysical characterization of recombinant proteins: A key to higher structural genomics successJournal of Structural Biology, 2010
- Pah enu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivoHuman Molecular Genetics, 2010
- Disease-causing missense mutations affect enzymatic activity, stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH)Human Molecular Genetics, 2008
- Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determinationProceedings of the National Academy of Sciences, 2006
- Intrinsic unstructuredness and abundance of PEST motifs in eukaryotic proteomesProteins: Structure, Function, and Bioinformatics, 2005
- Crystal Structures of Human Glutaryl-CoA Dehydrogenase with and without an Alternate Substrate: Structural Bases of Dehydrogenation and Decarboxylation Reactions,Biochemistry, 2004
- The Function of Arg-94 in the Oxidation and Decarboxylation of Glutaryl-CoA by Human Glutaryl-CoA DehydrogenaseJournal of Biological Chemistry, 2001
- Glutaryl-CoA Dehydrogenase Deficiency in Spain: Evidence of Two Groups of Patients, Genetically, and Biochemically DistinctPediatric Research, 2000
- Mutation analysis in glutaric aciduria type IJournal of Medical Genetics, 2000